133 related articles for article (PubMed ID: 28299737)
1. Time-Resolved Analysis of Matrix Metalloproteinase Substrates in Complex Samples.
Schlage P; Egli FE; Auf dem Keller U
Methods Mol Biol; 2017; 1579():185-198. PubMed ID: 28299737
[TBL] [Abstract][Full Text] [Related]
2. Proteomic approaches to uncover MMP function.
Schlage P; auf dem Keller U
Matrix Biol; 2015; 44-46():232-8. PubMed ID: 25603365
[TBL] [Abstract][Full Text] [Related]
3. Monitoring matrix metalloproteinase activity at the epidermal-dermal interface by SILAC-iTRAQ-TAILS.
Schlage P; Kockmann T; Kizhakkedathu JN; auf dem Keller U
Proteomics; 2015 Jul; 15(14):2491-502. PubMed ID: 25871442
[TBL] [Abstract][Full Text] [Related]
4. Identification of cellular MMP substrates using quantitative proteomics: isotope-coded affinity tags (ICAT) and isobaric tags for relative and absolute quantification (iTRAQ).
Butler GS; Dean RA; Morrison CJ; Overall CM
Methods Mol Biol; 2010; 622():451-70. PubMed ID: 20135298
[TBL] [Abstract][Full Text] [Related]
5. Multiplex N-terminome analysis of MMP-2 and MMP-9 substrate degradomes by iTRAQ-TAILS quantitative proteomics.
Prudova A; auf dem Keller U; Butler GS; Overall CM
Mol Cell Proteomics; 2010 May; 9(5):894-911. PubMed ID: 20305284
[TBL] [Abstract][Full Text] [Related]
6. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors.
Overall CM; Tam EM; Kappelhoff R; Connor A; Ewart T; Morrison CJ; Puente X; López-Otín C; Seth A
Biol Chem; 2004 Jun; 385(6):493-504. PubMed ID: 15255181
[TBL] [Abstract][Full Text] [Related]
7. Cell-based identification of natural substrates and cleavage sites for extracellular proteases by SILAC proteomics.
Gioia M; Foster LJ; Overall CM
Methods Mol Biol; 2009; 539():131-53. PubMed ID: 19377966
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase proteomics: substrates, targets, and therapy.
Morrison CJ; Butler GS; Rodríguez D; Overall CM
Curr Opin Cell Biol; 2009 Oct; 21(5):645-53. PubMed ID: 19616423
[TBL] [Abstract][Full Text] [Related]
9. Proteomics discovery of metalloproteinase substrates in the cellular context by iTRAQ labeling reveals a diverse MMP-2 substrate degradome.
Dean RA; Overall CM
Mol Cell Proteomics; 2007 Apr; 6(4):611-23. PubMed ID: 17200105
[TBL] [Abstract][Full Text] [Related]
10. Multidimensional Analysis of Protease Substrates and Their Cellular Origins in Mixed Secretomes from Multiple Cell Types.
Schlage P; Keller UAD
Methods Mol Biol; 2017; 1574():91-104. PubMed ID: 28315245
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics.
Rodríguez D; Morrison CJ; Overall CM
Biochim Biophys Acta; 2010 Jan; 1803(1):39-54. PubMed ID: 19800373
[TBL] [Abstract][Full Text] [Related]
12. Updated biological roles for matrix metalloproteinases and new "intracellular" substrates revealed by degradomics.
Butler GS; Overall CM
Biochemistry; 2009 Nov; 48(46):10830-45. PubMed ID: 19817485
[TBL] [Abstract][Full Text] [Related]
13. Identification of Protease Cleavage Sites and Substrates in Cancer by Carboxy-TAILS (C-TAILS).
Solis N; Overall CM
Methods Mol Biol; 2018; 1731():15-28. PubMed ID: 29318539
[TBL] [Abstract][Full Text] [Related]
14. Proteomic discovery of protease substrates.
Schilling O; Overall CM
Curr Opin Chem Biol; 2007 Feb; 11(1):36-45. PubMed ID: 17194619
[TBL] [Abstract][Full Text] [Related]
15. Active site specificity profiling of the matrix metalloproteinase family: Proteomic identification of 4300 cleavage sites by nine MMPs explored with structural and synthetic peptide cleavage analyses.
Eckhard U; Huesgen PF; Schilling O; Bellac CL; Butler GS; Cox JH; Dufour A; Goebeler V; Kappelhoff R; Keller UAD; Klein T; Lange PF; Marino G; Morrison CJ; Prudova A; Rodriguez D; Starr AE; Wang Y; Overall CM
Matrix Biol; 2016 Jan; 49():37-60. PubMed ID: 26407638
[TBL] [Abstract][Full Text] [Related]
16. Proteomic validation of protease drug targets: pharmacoproteomics of matrix metalloproteinase inhibitor drugs using isotope-coded affinity tag labelling and tandem mass spectrometry.
Butler GS; Overall CM
Curr Pharm Des; 2007; 13(3):263-70. PubMed ID: 17313360
[TBL] [Abstract][Full Text] [Related]
17. Identification of proteolytic products and natural protein N-termini by Terminal Amine Isotopic Labeling of Substrates (TAILS).
Doucet A; Kleifeld O; Kizhakkedathu JN; Overall CM
Methods Mol Biol; 2011; 753():273-87. PubMed ID: 21604129
[TBL] [Abstract][Full Text] [Related]
18. Membrane protease degradomics: proteomic identification and quantification of cell surface protease substrates.
Butler GS; Dean RA; Smith D; Overall CM
Methods Mol Biol; 2009; 528():159-76. PubMed ID: 19153692
[TBL] [Abstract][Full Text] [Related]
19. Time-resolved analysis of the matrix metalloproteinase 10 substrate degradome.
Schlage P; Egli FE; Nanni P; Wang LW; Kizhakkedathu JN; Apte SS; auf dem Keller U
Mol Cell Proteomics; 2014 Feb; 13(2):580-93. PubMed ID: 24281761
[TBL] [Abstract][Full Text] [Related]
20. Positional proteomics in the era of the human proteome project on the doorstep of precision medicine.
Eckhard U; Marino G; Butler GS; Overall CM
Biochimie; 2016 Mar; 122():110-8. PubMed ID: 26542287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
